These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24248600)

  • 21. Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells.
    Gonnella R; Yadav S; Gilardini Montani MS; Granato M; Santarelli R; Garufi A; D'Orazi G; Faggioni A; Cirone M
    Free Radic Biol Med; 2017 Nov; 112():327-335. PubMed ID: 28801242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation.
    Cai Q; Xiao B; Si H; Cervini A; Gao J; Lu J; Upadhyay SK; Verma SC; Robertson ES
    PLoS Pathog; 2012; 8(3):e1002566. PubMed ID: 22396649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells.
    Wies E; Mori Y; Hahn A; Kremmer E; Stürzl M; Fleckenstein B; Neipel F
    Blood; 2008 Jan; 111(1):320-7. PubMed ID: 17890449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.
    Rivas C; Thlick AE; Parravicini C; Moore PS; Chang Y
    J Virol; 2001 Jan; 75(1):429-38. PubMed ID: 11119611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase.
    Chang PC; Fitzgerald LD; Van Geelen A; Izumiya Y; Ellison TJ; Wang DH; Ann DK; Luciw PA; Kung HJ
    Cancer Res; 2009 Jul; 69(14):5681-9. PubMed ID: 19584288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural proteins of Kaposi's sarcoma-associated herpesvirus antagonize p53-mediated apoptosis.
    Chudasama P; Konrad A; Jochmann R; Lausen B; Holz P; Naschberger E; Neipel F; Britzen-Laurent N; Stürzl M
    Oncogene; 2015 Jan; 34(5):639-49. PubMed ID: 24469037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of c-Myc transcriptional activity by vIRF-3 of Kaposi sarcoma-associated herpesvirus.
    Lubyova B; Kellum MJ; Frisancho JA; Pitha PM
    J Biol Chem; 2007 Nov; 282(44):31944-53. PubMed ID: 17728244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor-2 inhibits type 1 interferon signalling by targeting interferon-stimulated gene factor-3.
    Mutocheluh M; Hindle L; Aresté C; Chanas SA; Butler LM; Lowry K; Shah K; Evans DJ; Blackbourn DJ
    J Gen Virol; 2011 Oct; 92(Pt 10):2394-2398. PubMed ID: 21697347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kaposi's sarcoma-associated herpesvirus vIRF2 protein utilizes an IFN-dependent pathway to regulate viral early gene expression.
    Koch S; Damas M; Freise A; Hage E; Dhingra A; Rückert J; Gallo A; Kremmer E; Tegge W; Brönstrup M; Brune W; Schulz TF
    PLoS Pathog; 2019 May; 15(5):e1007743. PubMed ID: 31059555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12).
    Muralidhar S; Veytsmann G; Chandran B; Ablashi D; Doniger J; Rosenthal LJ
    J Clin Virol; 2000 May; 16(3):203-13. PubMed ID: 10738139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus.
    Chiou CJ; Poole LJ; Kim PS; Ciufo DM; Cannon JS; ap Rhys CM; Alcendor DJ; Zong JC; Ambinder RF; Hayward GS
    J Virol; 2002 Apr; 76(7):3421-39. PubMed ID: 11884567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
    Burysek L; Yeow WS; Pitha PM
    J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) targets expression of cellular IRF4 and the Myc gene to facilitate lytic replication.
    Lee HR; Doğanay S; Chung B; Toth Z; Brulois K; Lee S; Kanketayeva Z; Feng P; Ha T; Jung JU
    J Virol; 2014 Feb; 88(4):2183-94. PubMed ID: 24335298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis.
    Seo T; Park J; Lee D; Hwang SG; Choe J
    J Virol; 2001 Jul; 75(13):6193-8. PubMed ID: 11390621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase.
    Burýsek L; Pitha PM
    J Virol; 2001 Mar; 75(5):2345-52. PubMed ID: 11160738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogenic KSHV-encoded interferon regulatory factor upregulates HMGB2 and CMPK1 expression to promote cell invasion by disrupting a complex lncRNA-OIP5-AS1/miR-218-5p network.
    Li W; Wang Q; Feng Q; Wang F; Yan Q; Gao SJ; Lu C
    PLoS Pathog; 2019 Jan; 15(1):e1007578. PubMed ID: 30699189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors.
    Lubyova B; Pitha PM
    J Virol; 2000 Sep; 74(17):8194-201. PubMed ID: 10933732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells.
    Santag S; Jäger W; Karsten CB; Kati S; Pietrek M; Steinemann D; Sarek G; Ojala PM; Schulz TF
    Oncogene; 2013 Aug; 32(32):3676-85. PubMed ID: 22964633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the promoter region of the viral interferon regulatory factor encoded by Kaposi's sarcoma-associated herpesvirus.
    Wang XP; Zhang YJ; Deng JH; Pan HY; Zhou FC; Montalvo EA; Gao SJ
    Oncogene; 2001 Jan; 20(4):523-30. PubMed ID: 11313983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.